KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Cash from Discontinued Operations: 2010-2011

Historic Cash from Discontinued Operations for Supernus Pharmaceuticals (SUPN) over the last 2 years, with Dec 2011 value amounting to $2.0 million.

  • Supernus Pharmaceuticals' Cash from Discontinued Operations was N/A to -$120,000 in Q4 2011 from the same period last year, while for Dec 2011 it was $2.0 million, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2011, which is 674.15% up from last year.
  • Supernus Pharmaceuticals' Cash from Discontinued Operations amounted to $2.0 million in FY2011, which was up 674.15% from -$352,000 recorded in FY2010.
  • Supernus Pharmaceuticals' Cash from Discontinued Operations' 5-year high stood at $2.0 million during FY2011, with a 5-year trough of -$352,000 in FY2010.
  • Its 2-year average for Cash from Discontinued Operations is $834,500, with a median of $834,500 in 2010.
  • Data for Supernus Pharmaceuticals' Cash from Discontinued Operations shows a peak YoY soared of 674.15% (in 2011) over the last 5 years.
  • Supernus Pharmaceuticals' Cash from Discontinued Operations (Yearly) stood at -$352,000 in 2010, then skyrocketed by 674.15% to $2.0 million in 2011.